Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miquel y Garriga is a prominent Spanish distributor of specialty chemicals and raw materials for the life sciences sector, including the pharmaceutical, nutraceutical, and cosmetic industries. Established in 1919 and headquartered in Barcelona, the company serves as a critical link in the supply chain for manufacturers across the Iberian Peninsula. In 2005, Miquel y Garriga was acquired by Barentz, a global leader in life science ingredient distribution, which significantly expanded its reach and product portfolio. The company provides a wide range of active pharmaceutical ingredients (APIs), excipients, and technical expertise to support product development and formulation. Today, it operates as the Spanish arm of the Barentz group, maintaining its legacy of local market knowledge combined with global sourcing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miquel y Garriga.